Biocryst Pharmaceuticals buy Grija
Start price
07.12.20
/
50%
€5.51
Target price
07.12.21
€25.00
Performance (%)
93.92%
End price
08.12.21
€10.69
Summary
This prediction ended on 08.12.21 with a price of €10.69. With a performance of 93.92% the BUY prediction by Grija was a big success. Grija has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biocryst Pharmaceuticals | 0.814% | 0.814% | 5.003% | -4.191% |
| iShares Core DAX® | -3.520% | -4.987% | 1.926% | 50.820% |
| iShares Nasdaq 100 | 0.261% | 1.102% | 15.434% | 90.843% |
| iShares Nikkei 225® | -4.953% | -3.352% | 29.010% | 51.211% |
| iShares S&P 500 | -0.823% | -0.042% | 10.814% | 62.945% |
According to Grija what are the pros and cons of Biocryst Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by Grija for this prediction
In the thread Biocryst Pharmaceuticals diskutieren
Kursziel geändert auf 9,0
Kursziel geändert auf 25,0
In the thread Trading Biocryst Pharmaceuticals
Die von Grija gewählte maximale Laufzeit wurde überschritten